DMD and Duchenne muscular dystrophy: For comparison, intra-arterial transplantation of donor mesoangioblasts in patients with Duchenne muscular dystrophy (DMD) resulted in 0.7% of engraftment in the muscles of the youngest patient, clearly insufficient to detect any clinical benefit, even though donor derived dystrophin was clearly detected (Cossu et al., 2015).